| Name | Title | Contact Details |
|---|---|---|
Austin Olson |
Finance Manager | Profile |
Vandana Sriram |
Chief Financial Officer | Profile |
Jennifer Liberi |
Director Global Commercial Enablement and Learning | Profile |
Kishore Malyavantham |
Senior Director, Assay Development, @Accelerator and Clinical Services | Profile |
Nuno Goncalves |
Vice President Of Product Management | Profile |
PAR Management is a Newton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
FluroTech is a technology and marketing company whose core business is focused on the commercialization of new technologies in the cannabis industry. FluroTech`s proprietary spectroscopy-based technology allows for the testing and identification of organic and inorganic compounds contained within biological samples derived from cannabis plants. Using the technology that was developed at the University of Calgary in conjunction with the University of Alberta, FluroTech has developed a two-part solution comprising an instrument called the CompleTestâ„¢ and consumable testing kits.
K-LaB Technologies, Inc. is a Dripping Springs, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Elektrofi is a biotechnology company focused on improving administration for a wide range of medicines including monoclonal antibodies, therapeutic proteins, and other large molecule drugs. Its breakthrough formulation platform enables stabilized, highly concentrated formulations for subcutaneous administration. The company is using this technology to transform therapies that are administered intravenously, and to enhance injectable products by reducing the volume and frequency of dosing. Elektrofi partners with pharmaceutical companies to jointly develop patient-friendly delivery solutions. Headquartered in Boston, the company`s founding team of MIT engineers and scientists are shaping the future of biologics delivery.
AIkido Pharma Inc. is a biotechnology development company with a diverse portfolio of early stage small-molecule anti-cancer therapeutics.